What happens to kidney care when Medicare’s CKCC model sunsets and LEAD begins?

In 590,282 California heart attack hospitalizations, a new PCI-capable facility within a 30-minute drive lowered 30-day mortality 20% in communities without prior access but did not change survival where the procedure was already available.

A NAACOS and Innovaccer survey of 116 leaders also found only 21% are tracking which of their patients have enrolled in the new chronic care model.

Paying membership fees with pretax employer dollars held cost growth to 0.9% a year, but the numbers come with caveats physicians should know before pitching employers.

Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.

Excited for the sunset of MIPS? Brace yourself for a replacement, not a repair. Here are four steps to prepare for it.

Encora X1, an FDA-cleared wrist device, uses mechanical rather than electrical neurostimulation, giving VA clinicians an option for patients who can't tolerate medication or have implanted electrical devices.

In a 13-patient test, an AI chat app answered questions about patients' brain data, and their feedback cut simulated false seizure alarms by 80%.